Last reviewed · How we verify
PT150
At a glance
| Generic name | PT150 |
|---|---|
| Also known as | Formerly ORG34517 |
| Sponsor | Pop Test Oncology LLC |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Initial Study Sesting Efficacy and Tolerability of PT150 for PTSD in Veterans (PHASE2)
- PT150 Drug for Use in Alcohol Use Disorder (PHASE1)
- Effects of Ethanol on the Pharmacokinetics of PT-150 (Formerly ORG34517) (PT150 PK Study) (PHASE1)
- Clinical Trial to Evaluate the Safety of PT150 (Formerly ORG34517) When it is Taken Concurrently With Alcohol (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- PT150 CI brief — competitive landscape report
- PT150 updates RSS · CI watch RSS
- Pop Test Oncology LLC portfolio CI